Insights

Innovative Oncology Portfolio Genmab's focus on next-generation antibody therapies, including bispecific T-cell engagers and immune checkpoint modulators, positions it as a leader in innovative cancer treatments. This opens sales opportunities with healthcare providers seeking cutting-edge solutions for difficult-to-treat cancers such as follicular lymphoma.

FDA-Approved Therapies The recent FDA approval of EPKINLY in combination with standard therapies demonstrates Genmab's strong product pipeline and regulatory success, providing opportunities to collaborate with hospitals and specialty clinics aiming to incorporate proven, highly effective biologics into their treatment options.

Robust Funding & Growth With a substantial revenue of over $10 billion and recent issuance of bonds and credit facilities, Genmab shows financial strength and growth potential, making it an attractive partner for biotech and pharmaceutical distributors looking to expand their portfolio with innovative biotech solutions.

Strategic Acquisitions & Partnerships Genmab’s active engagement in financings and acquisitions, including the planned purchase of Merus N.V., suggests opportunities to explore partnership or licensing deals that expand product reach or co-develop new therapies for oncology and hematology markets.

Global Market Presence Headquartered in Copenhagen with an international footprint across North America, Europe, and Asia Pacific, Genmab presents a compelling opportunity for global sales channels to include advanced biotech products, especially in regions with rising oncology treatment needs and investment in biologics.

Genmab Tech Stack

Genmab uses 8 technology products and services including QlikView, Ansible, SQL, and more. Explore Genmab's tech stack below.

  • QlikView
    Business Intelligence
  • Ansible
    Configuration Management
  • SQL
    Database
  • ISO/IEC 27001
    Governance, Risk And Compliance
  • Angular
    Javascript Frameworks
  • Vyond
    Marketing
  • Hootsuite
    Marketing
  • Microsoft
    Miscellaneous

Media & News

Genmab's Email Address Formats

Genmab uses at least 1 format(s):
Genmab Email FormatsExamplePercentage
F.Last@genmab.comJ.Doe@genmab.com
54%
LastFirst@genmab.comDoeJohn@genmab.com
27%
FirstL@genmab.comJohnD@genmab.com
13%
FiLast@genmab.comJoDoe@genmab.com
6%

Frequently Asked Questions

Where is Genmab's headquarters located?

Minus sign iconPlus sign icon
Genmab's main headquarters is located at Carl Jacobsens Vej 30 2500 Valby, DK. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Genmab's phone number?

Minus sign iconPlus sign icon
You can contact Genmab's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Genmab's stock symbol?

Minus sign iconPlus sign icon
Genmab is a publicly traded company; the company's stock symbol is GMAB.

What is Genmab's official website and social media links?

Minus sign iconPlus sign icon
Genmab's official website is genmab.com and has social profiles on LinkedIn.

How much revenue does Genmab generate?

Minus sign iconPlus sign icon
As of October 2025, Genmab's annual revenue is estimated to be $5B.

What is Genmab's SIC code NAICS code?

Minus sign iconPlus sign icon
Genmab's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Genmab have currently?

Minus sign iconPlus sign icon
As of October 2025, Genmab has approximately 2.6K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer: A. P.Chief Of Staff: P. M.Vice President Oncology Clinical Development: I. S.. Explore Genmab's employee directory with LeadIQ.

What industry does Genmab belong to?

Minus sign iconPlus sign icon
Genmab operates in the Biotechnology Research industry.

What technology does Genmab use?

Minus sign iconPlus sign icon
Genmab's tech stack includes QlikViewAnsibleSQLISO/IEC 27001AngularVyondHootsuiteMicrosoft.

What is Genmab's email format?

Minus sign iconPlus sign icon
Genmab's email format typically follows the pattern of F.Last@genmab.com. Find more Genmab email formats with LeadIQ.

How much funding has Genmab raised to date?

Minus sign iconPlus sign icon
As of October 2025, Genmab has raised $5.5B in funding. The last funding round occurred on Sep 29, 2025 for $5.5B.
Genmab

Genmab

Biotechnology Research2500 Valby, Denmark1001-5000 Employees

We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function enhanced antibodies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO®) antibody medicines. We are united by our core values: a passion for innovation, determination, integrity, and working as one team and respecting each other. When you work at Genmab you'll be part of a warm, fun, dynamic community seeking out and embracing the opportunity to build new and bold futures within a rapidly growing biotechnology company. Genmab is a place where you can be authentically you; you are empowered to innovate, build solutions and execute; you feel cared for and supported. In its totality, this makes working at Genmab an extra[not]ordinaryTM  experience. Established in 1999, we are headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com.  
Disclaimer: http://bit.ly/GENDisclaimer

Section iconCompany Overview

Headquarters
Carl Jacobsens Vej 30 2500 Valby, DK
Phone number
Website
genmab.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
GMAB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $5.5B

    Genmab has raised a total of $5.5B of funding over 6 rounds. Their latest funding round was raised on Sep 29, 2025 in the amount of $5.5B.

  • $10B

    Genmab's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $5.5B

    Genmab has raised a total of $5.5B of funding over 6 rounds. Their latest funding round was raised on Sep 29, 2025 in the amount of $5.5B.

  • $10B

    Genmab's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.